Applications

 

 

 

Applications in Hip Procedures

Improving Clinical and Economic Outcomes by Reducing Bleeding During and After Surgery

Orthopaedics New England

Total Hip Arthroplasty (THA) is performed using several approaches to the hip joint. The anterior approach allows the surgeon to approach the hip joint from the front of the hip without detachment of muscle during surgery, it is considered the only intermuscular and internervous approach for THA.

Salient Surgical Technologies’ patented TRANSCOLLATION™ technology remodels tissue collagen for vessel sealing, which reduces the need for blood transfusions and contributes intra-operatively to a clearer surgical site.

Dr. John Keggi uses the muscle sparing Anterior Total Hip Arthroplasty (THA) procedure. The anterior approach provides the patient with many benefits, as Dr. Keggi indicates:

“During the surgery the patient is in the supine position, allowing more direct access to the hip. The tensor fascia lata muscle is split directly anteriorally down to the hip avoiding the abductor muscles. The patient can experience a quicker recovery with the muscle sparing Anterior THA procedure.”

Regardless of your implant or approach, the AQUAMANTYS® System provides patient benefits for treating bleeding. Typical treatment areas include: Deep Subcutaneous Tissue, Branches of the Superior Gluteal Arteries and Veins, Short External Rotators, Bleeding from Circumflex Artery, Capsule prior to Capsulotomy, Femoral Neck prior to resection with the exception for Hip Resurfacing and the Obturator artery before and after reaming of the acetablum. 

To ensure optimal patient benefits certain areas should not be treated with the AQUAMANTYS system, they are: skin, superficial subcutaneous tissue, bone to be covered by an implant and neural structures.

The ability to treat large surface areas or spot treat specific vessels, TRANSCOLLATION technology provides the most innovative method for minimizing bleeding and preserving the patients hemoglobin.

Contact your local Salient Sales Representative to learn more about this product.

Hip Treatment Areas Hip Treatment Areas

Whether it is treating areas actively bleeding during surgery, or treating areas likely to bleed after surgery, the AQUAMANTYS® System preserves the patient's own hemoglobin levels, therefore reducing the risk of transfusion and the need for pre-donation. Less bleeding also reduces the need for a postoperative drain. In addition, bleeding can contribute to increased pain and swelling during recovery. TRANSCOLLATION™ technology in orthopaedic surgery may:

  • Improve the patient experience by reducing the risk of transfusion related infections.
  • Reduce hospital length of stay.
  • Reduce post-surgical pain and swelling by reducing postoperative hematomas.
  • Be especially beneficial for high-risk, multiple-comorbidity patient groups susceptible to increased blood loss.
  • Preserve the patient's own blood.

AQUAMANTYS® System in ASI Total Hip Arthroplasty

  • Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999; 81(1):2-10.

  • Rosen MJ. Transcollation technology for primary total joint replacement: Clinical and economic benefits. Data on file.

  • A New Look at Blood Transfusion: Evaluation of the risks and benefits prompts careful blood management. Joint Commission Perspectives on Patient Safety, January 2007, Volume 7, Issue 1.

  • Rosenberg AG. Reducing blood loss in total joint surgery with a saline-coupled bipolar sealing technology. J Arthroplasty. 2007; 22(4 Suppl 1):82-5.

  • Bushnell BD, Horton JK, McDonald MF, Robertson PG. Perioperative medical comorbidities in the orthopaedic patient. J Am Acad Orthop Surg 2008 16: 216-227.